About this Journal Submit a Manuscript Table of Contents
ISRN Biochemistry
Volume 2013 (2013), Article ID 728392, 11 pages
http://dx.doi.org/10.1155/2013/728392
Review Article

Cellular and Biochemical Mechanisms of the Retroviral Restriction Factor SAMHD1

Center for Retrovirus Research, Department of Veterinary Biosciences and Department of Microbial Infection and Immunity, The Ohio State University, 1900 Coffey Road, Columbus, OH 43210, USA

Received 5 June 2013; Accepted 7 July 2013

Academic Editors: I. de la Serna and H. Himeno

Copyright © 2013 Li Wu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. P. Goff, “Host factors exploited by retroviruses,” Nature Reviews Microbiology, vol. 5, no. 4, pp. 253–263, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Engelman and P. Cherepanov, “The structural biology of HIV-1: mechanistic and therapeutic insights,” Nature Reviews Microbiology, vol. 10, no. 4, pp. 279–290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. A. L. Brass, D. M. Dykxhoorn, Y. Benita et al., “Identification of host proteins required for HIV infection through a functional genomic screen,” Science, vol. 319, no. 5865, pp. 921–926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. König, Y. Zhou, D. Elleder et al., “Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication,” Cell, vol. 135, no. 1, pp. 49–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Zhou, M. Xu, Q. Huang et al., “Genome-scale RNAi screen for host factors required for HIV replication,” Cell Host and Microbe, vol. 4, no. 5, pp. 495–504, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. F. D. Bushman, N. Malani, J. Fernandes et al., “Host cell factors in HIV replication: meta-analysis of genome-wide studies,” PLoS Pathogens, vol. 5, no. 5, Article ID e1000437, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. P. D. Bieniasz, “Intrinsic immunity: a front-line defense against viral attack,” Nature Immunology, vol. 5, no. 11, pp. 1109–1115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Wolf and S. P. Goff, “Host restriction factors blocking retroviral replication,” Annual Review of Genetics, vol. 42, pp. 143–163, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. R. S. Harris and M. T. Liddament, “Retroviral restriction by APOBEC proteins,” Nature Reviews Immunology, vol. 4, no. 11, pp. 868–877, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Wu, “Biology of HIV mucosal transmission,” Current Opinion in HIV and AIDS, vol. 3, no. 5, pp. 534–540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. C. M. Coleman and L. Wu, “HIV interactions with monocytes and dendritic cells: viral latency and reservoirs,” Retrovirology, vol. 6, article 51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Wu and V. N. KewalRamani, “Dendritic-cell interactions with HIV: infection and viral dissemination,” Nature Reviews Immunology, vol. 6, no. 11, pp. 859–868, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Eisele and R. F. Siliciano, “Redefining the viral reservoirs that prevent HIV-1 eradication,” Immunity, vol. 37, no. 3, pp. 377–388, 2012. View at Publisher · View at Google Scholar
  14. J. Luban, “Innate immune sensing of HIV-1 by dendritic cells,” Cell Host Microbe, vol. 12, no. 4, pp. 408–418, 2012. View at Publisher · View at Google Scholar
  15. L. Wu, “SAMHD1: a new contributor to HIV-1 restriction in resting CD4+ T-cells,” Retrovirology, vol. 9, no. 1, article 88, 2012. View at Publisher · View at Google Scholar
  16. A. M. Sheehy, N. C. Gaddis, J. D. Choi, and M. H. Malim, “Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein,” Nature, vol. 418, no. 6898, pp. 646–650, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Stremlau, C. M. Owens, M. J. Perron, M. Kiessling, P. Autissier, and J. Sodroski, “The cytoplasmic body component TRIM5α restricts HIV-1 infection in old world monkeys,” Nature, vol. 427, no. 6977, pp. 848–853, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. S. J. D. Neil, T. Zang, and P. D. Bieniasz, “Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu,” Nature, vol. 451, no. 7177, pp. 425–430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. N. van Damme, D. Goff, C. Katsura et al., “The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein,” Cell Host and Microbe, vol. 3, no. 4, pp. 245–252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. R. S. Harris, J. F. Hultquist, and D. T. Evans, “The restriction factors of human immunodeficiency virus,” The Journal of Biological Chemistry, vol. 287, no. 49, pp. 40875–40883, 2012. View at Publisher · View at Google Scholar
  21. N. Laguette, B. Sobhian, N. Casartelli et al., “SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx,” Nature, vol. 474, no. 7353, pp. 654–657, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Hrecka, C. Hao, M. Gierszewska et al., “Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein,” Nature, vol. 474, no. 7353, pp. 658–661, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Berger, A. F. R. Sommer, J. Zwarg et al., “SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection,” PLoS Pathogens, vol. 7, no. 12, Article ID e1002425, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. M. Baldauf, X. Pan, E. Erikson et al., “SAMHD1 restricts HIV-1 infection in resting CD4+ T cells,” Nature Medicine, vol. 18, no. 11, pp. 1682–1689, 2012. View at Publisher · View at Google Scholar
  25. B. Descours, A. Cribier, C. Chable-Bessia et al., “SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4+ T-cells,” Retrovirology, vol. 9, no. 1, article 87, 2012.
  26. T. E. White, A. Brandariz-Nunez, J. C. Valle-Casuso et al., “Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1,” Virology, vol. 436, no. 1, pp. 81–90, 2012.
  27. T. Gramberg, T. Kahle, N. Bloch et al., “Restriction of diverse retroviruses by SAMHD1,” Retrovirology, vol. 10, article 26, 2013.
  28. C. St Gelais and L. Wu, “SAMHD1: a new insight into HIV-1 restriction in myeloid cells,” Retrovirology, vol. 8, article 55, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Manel and D. R. Littman, “Hiding in plain sight: how HIV evades innate immune responses,” Cell, vol. 147, no. 2, pp. 271–274, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Planelles, “Restricted access to myeloid cells explained,” Viruses, vol. 3, no. 9, pp. 1624–1633, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. H. Zheng, K. T. Jeang, and K. Tokunaga, “Host restriction factors in retroviral infection: promises in virus-host interaction,” Retrovirology, vol. 9, article 112, 2012.
  32. T. Schaller, C. Goujon, and M. H. Malim, “AIDS/HIV. HIV interplay with SAMHD1,” Science, vol. 335, no. 6074, pp. 1313–1314, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Laguette and M. Benkirane, “How SAMHD1changes our view of viral restriction,” Trends in Immunology, vol. 33, no. 1, pp. 26–33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Ayinde, N. Casartelli, and O. Schwartz, “Restricting HIV the SAMHD1 way: through nucleotide starvation,” Nature Reviews Microbiology, vol. 10, no. 10, pp. 675–680, 2012. View at Publisher · View at Google Scholar
  35. C. Goujon, L. Jarrosson-Wuillème, J. Bernaud, D. Rigal, J.-. Darlix, and A. Cimarelli, “With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIVMAC,” Gene Therapy, vol. 13, no. 12, pp. 991–994, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Goujon, L. Rivière, L. Jarrosson-Wuilleme et al., “SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells,” Retrovirology, vol. 4, article 2, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Goujon, V. Arfi, T. Pertel et al., “Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells,” Journal of Virology, vol. 82, no. 24, pp. 12335–12345, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Schüle, B. Kloke, J. K. Kaiser et al., “Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj,” PLoS ONE, vol. 4, no. 9, Article ID e7098, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Kaushik, X. Zhu, R. Stranska, Y. Wu, and M. Stevenson, “A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection,” Cell Host and Microbe, vol. 6, no. 1, pp. 68–80, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Sharova, Y. Wu, X. Zhu et al., “Primate lentiviral Vpx commandeers DDB1 to counteract a macrophage restriction,” PLoS Pathogens, vol. 4, no. 5, Article ID e1000057, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Fujita, M. Otsuka, M. Miyoshi, B. Khamsri, M. Nomaguchi, and A. Adachi, “Vpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophages,” Journal of Virology, vol. 82, no. 15, pp. 7752–7756, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Srivastava, S. K. Swanson, N. Manel, L. Florens, M. P. Washburn, and J. Skowronski, “Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection,” PLoS Pathogens, vol. 4, no. 5, Article ID e1000059, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Bergamaschi, D. Ayinde, A. David et al., “The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection,” Journal of Virology, vol. 83, no. 10, pp. 4854–4860, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Ayinde, C. Maudet, C. Transy, and F. Margottin-Goguet, “Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?” Retrovirology, vol. 7, article 35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. M. H. Malim and M. Emerman, “HIV-1 accessory proteins—ensuring viral survival in a hostile environment,” Cell Host and Microbe, vol. 3, no. 6, pp. 388–398, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Berger, S. Durand, C. Goujon et al., “A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1-derived lentiviral vectors,” Nature Protocols, vol. 6, no. 6, pp. 806–816, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Sunseri, M. O'Brien, N. Bhardwaj, and N. R. Landau, “Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells,” Journal of virology, vol. 85, no. 13, pp. 6263–6274, 2011. View at Scopus
  48. N. Manel, B. Hogstad, Y. Wang, D. E. Levy, D. Unutmaz, and D. R. Littman, “A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells,” Nature, vol. 467, no. 7312, pp. 214–217, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. J. Ahn, C. Hao, J. Yan et al., “HIV/Simian Immunodeficiency Virus (SIV) accessory virulence factor Vpx loads the host cell restriction factor SAMHD1 onto the E3 ubiquitin ligase complex CRL4DCAF1,” The Journal of Biological Chemistry, vol. 287, no. 15, pp. 12550–12558, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. W. Wei, H. Guo, X. Han et al., “A novel DCAF1-binding motif required for Vpx-mediated degradation of nuclear SAMHD1 and Vpr-induced G2 arrest,” Cellular Microbiology, vol. 14, no. 11, pp. 1745–1756, 2012. View at Publisher · View at Google Scholar
  51. J. S. Gibbs, A. A. Lackner, S. M. Lang et al., “Progression to AIDS in the absence of a gene for vpr or vpx,” Journal of Virology, vol. 69, no. 4, pp. 2378–2383, 1995. View at Scopus
  52. V. M. Hirsch, M. E. Sharkey, C. R. Brown et al., “Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification,” Nature Medicine, vol. 4, no. 12, pp. 1401–1408, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Belshan, J. T. Kimata, C. Brown et al., “Vpx is critical for SIVmne infection of pigtail macaques,” Retrovirology, vol. 9, article 32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Laguette, N. Rahm, B. Sobhian et al., “Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein,” Cell Host and Microbe, vol. 11, no. 2, pp. 205–217, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. E. S. Lim, O. I. Fregoso, C. O. McCoy, F. A. Matsen, H. S. Malik, and M. Emerman, “The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx,” Cell Host and Microbe, vol. 11, no. 2, pp. 194–204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Zhang, S. de Silva, J. Wang, and L. Wu, “Co-evolution of primate SAMHD1 and Lentivirus Vpx leads to the loss of the vpx gene in HIV-1 ancestor,” PLoS ONE, vol. 7, no. 5, Article ID e37477, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. M. D. Zimmerman, M. Proudfoot, A. Yakunin, and W. Minor, “Structural insight into the mechanism of substrate specificity and catalytic activity of an HD-domain phosphohydrolase: the 5′-deoxyribonucleotidase YfbR from Escherichia coli,” Journal of Molecular Biology, vol. 378, no. 1, pp. 215–226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. D. C. Goldstone, V. Ennis-Adeniran, J. J. Hedden et al., “HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase,” Nature, vol. 480, no. 7377, pp. 379–382, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. R. D. Powell, P. J. Holland, T. Hollis, and F. W. Perrino, “Aicardi-Goutières syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase,” The Journal of Biological Chemistry, vol. 286, no. 51, pp. 43596–43600, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. A. Brandariz-Nunez, J. C. Valle-Casuso, T. E. White et al., “Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac,” Retrovirology, vol. 9, article 49, 2012.
  61. H. Hofmann, E. C. Logue, N. Bloch et al., “The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleus,” Journal of Virology, vol. 86, no. 23, pp. 12552–12560, 2012. View at Publisher · View at Google Scholar
  62. S. Coon, D. Wang, and L. Wu, “Polymorphisms of the SAMHD1 gene are not associated with the infection and natural control of HIV type 1 in Europeans and African-Americans,” AIDS Research and Human Retroviruses, vol. 28, no. 12, pp. 1565–1573, 2012. View at Publisher · View at Google Scholar
  63. B. Kim, L. A. Nguyen, W. Daddacha, and J. A. Hollenbaugh, “Tight interplay among SAMHD1 protein level, cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages,” The Journal of Biological Chemistry, vol. 287, no. 26, pp. 21570–21574, 2012. View at Publisher · View at Google Scholar
  64. P. Reichard, “Interactions between deoxyribonucleotide and DNA synthesis,” Annual Review of Biochemistry, vol. 57, pp. 349–374, 1988. View at Scopus
  65. S. de Silva, H. Hoy, T. S. Hake, H. K. Wong, P. Porcu, and L. Wu, “Promoter methylation regulates SAMHD1 gene expression in human CD4+ T cells,” The Journal of Biological Chemistry, vol. 288, no. 13, pp. 9284–9292, 2013. View at Publisher · View at Google Scholar
  66. C. St Gelais, S. de Silva, S. M. Amie et al., “SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons,” Retrovirology, vol. 9, no. 1, article 105, 2012.
  67. S. Welbourn, E. Miyagi, T. E. White, F. Diaz-Griffero, and K. Strebel, “Identification and characterization of naturally occurring splice variants of SAMHD1,” Retrovirology, vol. 9, no. 1, article 86, 2012.
  68. S. B. Baylin and P. A. Jones, “A decade of exploring the cancer epigenome-biological and translational implications,” Nature Reviews Cancer, vol. 11, no. 10, pp. 726–734, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. G. I. Rice, J. Bond, A. Asipu et al., “Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response,” Nature Genetics, vol. 41, no. 7, pp. 829–832, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. N. Li, W. Zhang, and X. Cao, “Identification of human homologue of mouse IFN-γ induced protein from human dendritic cells,” Immunology Letters, vol. 74, no. 3, pp. 221–224, 2000. View at Publisher · View at Google Scholar · View at Scopus
  71. N. Yan, A. D. Regalado-Magdos, B. Stiggelbout, M. A. Lee-Kirsch, and J. Lieberman, “The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1,” Nature Immunology, vol. 11, no. 11, pp. 1005–1013, 2010. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Yu, S. M. Usmani, A. Borch et al., “The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals,” Retrovirology, vol. 10, article 27, 2013.
  73. G. Doitsh, M. Cavrois, K. G. Lassen et al., “Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue,” Cell, vol. 143, no. 5, pp. 789–801, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. W. Hübner, G. P. McNerney, P. Chen et al., “Quantitative 3D video microscopy of HIV transfer across T cell virological synapses,” Science, vol. 323, no. 5922, pp. 1743–1747, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. P. Chen, W. Hübner, M. A. Spinelli, and B. K. Chen, “Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses,” Journal of Virology, vol. 81, no. 22, pp. 12582–12595, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. W. Mothes, N. M. Sherer, J. Jin, and P. Zhong, “Virus cell-to-cell transmission,” Journal of Virology, vol. 84, no. 17, pp. 8360–8368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. I. Puigdomenech, N. Casartelli, F. Porrot, and O. Schwartz, “SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocyte-derived dendritic cells,” Journal of Virology, vol. 87, no. 5, pp. 2846–2856, 2013. View at Publisher · View at Google Scholar
  78. E. Pauls, E. Jimenez, A. Ruiz et al., “Restriction of HIV-1 replication in primary macrophages by IL-12 and IL-18 through the upregulation of SAMHD1,” Journal of Immunology, vol. 190, no. 9, pp. 4736–4741, 2013. View at Publisher · View at Google Scholar
  79. S. M. Amie, E. Noble, and B. Kim, “Intracellular nucleotide levels and the control of retroviral infections,” Virology, vol. 436, no. 2, pp. 247–254, 2013. View at Publisher · View at Google Scholar
  80. W. Y. Gao, A. Cara, R. C. Gallo, and F. Lori, “Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 19, pp. 8925–8928, 1993. View at Publisher · View at Google Scholar · View at Scopus
  81. T. L. Diamond, M. Roshal, V. K. Jamburuthugoda et al., “Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase,” The Journal of Biological Chemistry, vol. 279, no. 49, pp. 51545–51553, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. J. A. Zack, S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen, “HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure,” Cell, vol. 61, no. 2, pp. 213–222, 1990. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Lahouassa, W. Daddacha, H. Hofmann et al., “SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates,” Nature Immunology, vol. 13, no. 3, pp. 223–228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. K. S. Jones, C. Petrow-Sadowski, Y. K. Huang, D. C. Bertolette, and F. W. Ruscetti, “Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4+ T cells,” Nature Medicine, vol. 14, no. 4, pp. 429–436, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. T. E. White, A. Brandariz-Nunez, J. C. Valle-Casuso et al., “The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation,” Cell Host and Microbe, vol. 13, no. 4, pp. 441–451, 2013. View at Publisher · View at Google Scholar
  86. A. Cribier, B. Descours, A. L. Valadao, N. Laguette, and M. Benkirane, “Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1,” Cell Reports, vol. 3, no. 4, pp. 1036–1043, 2013. View at Publisher · View at Google Scholar
  87. J. Yan, S. Kaur, M. Delucia et al., “Tetramerization of SAMHD1 is required for biological activity and inhibition of HIV infection,” The Journal of Biological Chemistry, vol. 288, no. 15, pp. 10406–10417, 2013. View at Publisher · View at Google Scholar
  88. M. Delucia, J. Mehrens, Y. Wu, and J. Ahn, “HIV-2 and SIVmac accessory virulence factor Vpx down-regulates SAMHD1 catalysis prior to proteasome-dependent degradation,” The Journal of Biological Chemistry, 2013. View at Publisher · View at Google Scholar
  89. A. Goncalves, E. Karayel, G. I. Rice et al., “SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations,” Human Mutation, vol. 33, no. 7, pp. 1116–1122, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. V. Tungler, W. Staroske, B. Kind et al., “Single-stranded nucleic acids promote SAMHD1 complex formation,” Journal of Molecular Medicine, vol. 91, no. 6, pp. 759–770, 2013. View at Publisher · View at Google Scholar
  91. N. Beloglazova, R. Flick, A. Tchigvintsev et al., “Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction,” The Journal of Biological Chemistry, vol. 288, no. 12, pp. 8101–8110, 2013. View at Publisher · View at Google Scholar
  92. T. Pertel, C. Reinhard, and J. Luban, “Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon,” Retrovirology, vol. 8, article 49, 2011. View at Publisher · View at Google Scholar · View at Scopus
  93. L. Dragin, L. A. Nguyen, H. Lahouassa et al., “Interferon block to HIV-1 transduction in macrophages despite SAMHD1 degradation and high deoxynucleoside triphosphates supply,” Retrovirology, vol. 10, article 30, 2013.
  94. C. Goujon, T. Schaller, R. P. Galao et al., “Evidence for IFNα-induced, SAMHD1-independent inhibitors of early HIV-1 infection,” Retrovirology, vol. 10, article 23, 2013.
  95. J. W. Schoggins, S. J. Wilson, M. Panis et al., “A diverse range of gene products are effectors of the type i interferon antiviral response,” Nature, vol. 472, no. 7344, pp. 481–485, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. B. K. Thielen, J. P. McNevin, M. J. McElrath, B. V. S. Hunt, K. C. Klein, and J. R. Lingappa, “Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms,” The Journal of Biological Chemistry, vol. 285, no. 36, pp. 27753–27766, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. G. Berger, S. Durand, G. Fargier et al., “Apobec3a is a specific inhibitor of the early phases of hiv-1 infection in myeloid cells,” PLoS Pathogens, vol. 7, no. 9, Article ID e1002221, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. C. Dong, A. M. Janas, J. Wang, W. J. Olson, and L. Wu, “Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection,” Journal of Virology, vol. 81, no. 20, pp. 11352–11362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. C. Dong, C. Kwas, and L. Wu, “Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes,” Journal of Virology, vol. 83, no. 8, pp. 3518–3527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. L. Ganesh, E. Burstein, A. Guha-Niyogi et al., “The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes,” Nature, vol. 426, no. 6968, pp. 853–857, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. C. Goujon and M. H. Malim, “Characterization of the α interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells,” Journal of Virology, vol. 84, no. 18, pp. 9254–9266, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Li, E. Kao, X. Gao et al., “Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11,” Nature, vol. 491, no. 7422, pp. 125–128, 2012. View at Publisher · View at Google Scholar
  103. W. Sohn, D. Kim, K. Lee et al., “Novel transcriptional regulation of the schlafen-2 gene in macrophages in response to TLR-triggered stimulation,” Molecular Immunology, vol. 44, no. 13, pp. 3273–3282, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. T. Pertel, S. Hausmann, D. Morger et al., “TRIM5 is an innate immune sensor for the retrovirus capsid lattice,” Nature, vol. 472, no. 7343, pp. 361–365, 2011. View at Publisher · View at Google Scholar · View at Scopus
  105. R. P. Galao, A. Le Tortorec, S. Pickering, T. Kueck, and S. J. Neil, “Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses,” Cell Host and Microbe, vol. 12, no. 5, pp. 633–644, 2012. View at Publisher · View at Google Scholar
  106. A. Tokarev, M. Suarez, W. Kwan, K. Fitzpatrick, R. Singh, and J. Guatelli, “Stimulation of NF-κB activity by the HIV restriction factor BST2,” Journal of Virology, vol. 87, no. 4, pp. 2046–2057, 2013. View at Publisher · View at Google Scholar
  107. J. Wu, L. Sun, X. Chen et al., “Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA,” Science, vol. 339, no. 6121, pp. 826–830, 2013. View at Publisher · View at Google Scholar
  108. L. Sun, J. Wu, F. Du, X. Chen, and Z. J. Chen, “Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway,” Science, vol. 339, no. 6121, pp. 786–791, 2013. View at Publisher · View at Google Scholar
  109. P. Gao, M. Ascano, Y. Wu et al., “Cyclic [G(2′, 5′)pA(3′, 5′)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase,” Cell, vol. 153, no. 5, pp. 1094–1107, 2013. View at Publisher · View at Google Scholar